Advance Search
LI Jiancheng, XU Gangzheng. Value of hypersensitivity C-reactive protein in predicting the prognosis of coronary heart disease patients with interventional therapy[J]. Journal of Clinical Medicine in Practice, 2020, 24(18): 34-36. DOI: 10.7619/jcmp.202018009
Citation: LI Jiancheng, XU Gangzheng. Value of hypersensitivity C-reactive protein in predicting the prognosis of coronary heart disease patients with interventional therapy[J]. Journal of Clinical Medicine in Practice, 2020, 24(18): 34-36. DOI: 10.7619/jcmp.202018009
shu

Value of hypersensitivity C-reactive protein in predicting the prognosis of coronary heart disease patients with interventional therapy

  • 1. First Department of Cardiovascular Medicine, Shangluo City Central Hospital, Shangluo, Shaanxi, 726000;

  • 2. Department of Cardiovascular Medicine, Fuping County Hospital of Traditional Chinese Medicine, Fuping, Shaanxi, 711700

More Information
  • Received Date: April 24, 2020
    Graphical Abstract
    • Abstract
  • Objective To observe the significance of hypersensitivity C-reactive protein(hs-CRP)in predicting the prognosis of coronary heart disease patients with interventional therapy. Methods A total of 240 coronary heart disease patients in our hospital were selected as observation group(given percutaneous coronary intervention), and 260 coronary angiography patients were selected as control group during the same period. The serum of all recruiters were collected for detection of levels of hs-CRP. Patients in the observation group had regular visits in the hospital, and its incidence of adverse events was recorded. Results Compared with the control group, the level of hs-CRP in the observation group was significantly higher(P<0.05). Compared with preoperation, hs-CRP level after intervention was significantly higher(P<0.05). The incidence of adverse cardiovascular events in hs-CRP ≥3 ng/L group was significantly higher than hs-CRP <3 mg/L(13.66% versus 2.53%, P<0.05). Conclusion Patients with coronary heart disease have obvious local inflammatory response after interventional therapy. Detection of serum hs-CRP level has a certain effect in prediction of prognosis.
    • FullText(HTML)
    • References (14)
  • 张冬花, 李志忠, 张京梅, 等. 红细胞分布宽度与冠心病患者经皮冠状动脉介入治疗术后支架内再狭窄的相关性研究[J]. 中国综合临床, 2017, 33(12): 1084-1088.
    朱勇, 张美春, 高孟秋, 等. 替格瑞洛与氯吡格雷对冠心病患者冠状动脉介入术后炎症因子的影响[J]. 中国临床药理学杂志, 2016, 32(14): 1257-1260.
    袁玉亮, 王娜. 丹参多酚酸盐治疗冠心病的效果及对患者免疫炎症反应的影响[J]. 国际免疫学杂志, 2018, 41(2): 238-242.
    郝名媛, 李旭, 敬锐, 等. 冠心病患者心外膜脂肪组织及其炎症因子对左心室舒张功能的影响[J]. 中华医学杂志, 2018, 98(27): 2168-2171.
    戴雯, 李艳. 冠心病患者血清sd-LDL和hs-CRP与冠状动脉狭窄程度的相关性研究[J]. 海南医学, 2017, 28(7): 1045-1047.
    陈维. 不同剂量缬沙坦对冠状动脉介入术后患者血清中PPARγ含量及机体炎症程度的影响[J]. 海南医学院学报, 2016, 22(20): 2401-2404.
    韩雅玲, 李洋. 中国冠心病介入治疗发展历程[J]. 中华心血管病杂志, 2017, 45(8): 654-661.
    尹叶全. 阿司匹林联合氯吡格雷对冠心病心绞痛患者血清hs-CRP、TNF-α及IL-6水平的影响研究[J]. 解剖学研究, 2018, 40(3): 178-181.
    许晓伟, 刘亚丽, 苏维芳. 瑞舒伐他汀对急性冠状动脉综合征患者经皮冠状动脉介入术后高敏C反应蛋白与基质金属蛋白酶影响的研究[J]. 山西医药杂志, 2016, 45(9): 1046-1048.
    李小林, 程伟宁, 黄龙虎, 等. 冠心病患者血清脂肪因子与超敏C反应蛋白水平变化及临床意义[J]. 中国心血管病研究, 2019, 17(3): 223-226.
    刘冰, 曹鸿雁, 王金春, 等. ACS患者Hcy、hs-CRP、SHG与GRACE评分的相关性研究[J]. 中国急救复苏与灾害医学杂志, 2019, 14(3): 205-207.
    赵凤玲, 常玉洁, 董雪莲, 等. 热敏灸联合活血化瘀解毒方对冠心病心绞痛病人血清瘦素、C-反应蛋白及肿瘤坏死因子-α的影响[J]. 中西医结合心脑血管病杂志, 2018, 16(12): 1719-1722.
    熊萱, 张远, 喻冬柯, 等. 中国冠心病患者ApoE基因型和高敏C反应蛋白临床相关性研究[J]. 四川医学, 2019, 40(6): 549-552.
    王智, 邱林, 龚艳君, 等. 冠心病患者冠状动脉介入治疗前后血浆高敏C反应蛋白水平的变化及其与主要不良心血管事件的关系[J]. 中国动脉硬化杂志, 2016, 24(11): 1104-1108.
    • Related Articles

  • Related Articles

    [1]LI Xiaoyu, ZHANG Yongyong, QIN Juan, YANG Zhongxin. Changes of serological indexes and prognosis of acute coronary syndrome patients after percutaneous coronary intervention[J]. Journal of Clinical Medicine in Practice, 2023, 27(23): 60-62, 67. DOI: 10.7619/jcmp.20231532
    [2]SHA Feiyan, CHEN Peipei, LI Wen, XIE Renbing. Values of CHA2DS2-VASc score and Global Registry of Acute Coronary Events risk score in predicting poor prognosis of patients with atrial fibrillation after percutaneous coronary intervention[J]. Journal of Clinical Medicine in Practice, 2023, 27(3): 46-51. DOI: 10.7619/jcmp.20222276
    [3]LIU Yanqi, ZHENG Guanqun, CHEN Zhixian, JIN Xiaoqi, SHENG Xiaodong, WANG Zhiqiang. Correlation between plasma trimethylamine-N-oxide and coronary heart disease and its effect on the prognosis of patients with coronary heart disease[J]. Journal of Clinical Medicine in Practice, 2022, 26(24): 90-96. DOI: 10.7619/jcmp.20221667
    [4]LIANG Jing, HE Xueling, TANG Qian, TU Chongfang, QIAN Kun, LIU Hui. Relationships between red blood cell distribution width and in-stent restenosis as well as prognosis after percutaneous coronary intervention[J]. Journal of Clinical Medicine in Practice, 2021, 25(21): 63-66, 73. DOI: 10.7619/jcmp.20213620
    [5]GONG Xiaoyong, HU Xiaowei, HE Fei, HU Jianping. Correlations between serum levels of brain natriuretic peptide, hypersensitive C-reactive protein as well as creatine kinase isoenzyme and prognosis of patients after percutaneous coronary intervention[J]. Journal of Clinical Medicine in Practice, 2021, 25(11): 72-76. DOI: 10.7619/jcmp.20211053
    [6]SUN Huimin. Effect of rehabilitation nursing on postoperative recovery of coronary heart disease patients with percutaneous coronary intervention[J]. Journal of Clinical Medicine in Practice, 2019, 23(14): 56-58,79. DOI: 10.7619/jcmp.201914015
    [7]MENG Xiaofeng, SUI Shihua, SU Hao. Comparison in therapeutic effects and prognosis of interventional therapy in coronary heart disease patients with different blood glucose levels[J]. Journal of Clinical Medicine in Practice, 2016, (13): 1-4. DOI: 10.7619/jcmp.201613001
    [8]WANG Yanhua. Clinical significance of changes in levels of high sensitive C-reactive protein and cardiac troponin-T in patients with coronary heart disease after percutaneous coronary intervention[J]. Journal of Clinical Medicine in Practice, 2015, (7): 29-31. DOI: 10.7619/jcmp.201507007
    [9]WANG Di. Relationship of hs-CRP with severity of coronary atherosclerosis and prognosis in coronary heart disease[J]. Journal of Clinical Medicine in Practice, 2013, (15): 96-97,102. DOI: 10.7619/jcmp.201315035
    [10]ZHANG Ying, QIN Shu, ZHANG Dongyin, WANG Kechun. Relationship between high-sensitivity C-reactive protein and the severity and prognosis of coronary atherosclerosis of coronary heart disease[J]. Journal of Clinical Medicine in Practice, 2012, (23): 45-48.

  • Cited by

    Periodical cited type(2)

    1. 姬林娟，田欣，芮涛，姚永伟. 白细胞与红细胞比容比值对急性ST段抬高型心肌梗死再灌注治疗后院内主要不良心血管事件的预测价值. 实用临床医药杂志. 2024(15): 14-18+25 . 本站查看
    2. 莫妮娜. 冠心病冠状动脉介入术患者心功能改变及相关影响因素. 吉林医学. 2022(11): 2943-2946 .

    Other cited types(1)

Catalog

    Get Citation
    PDF
    XML
    Article views (283) PDF downloads (12) Cited by(3)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    © 2020 《实用临床医药杂志》编辑部

    Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    Supported by: Beijing Renhe Information Technology Co., Ltd.   Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return